Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Total article views   HTML views PDF downloads Totals
23,070 Dovepress* 12,756+ 2,214 14,970
PubMed Central* 10,314 893 11,207
Totals 23,070 3,107 26,177
*Since 20 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar